Ensign Peak Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,811
| Closed | -$581K | – | 2019 |
|
|
2022
Q3 | $581K | Hold |
10,811
| – | – | ﹤0.01% | 1376 |
|
|
2022
Q2 | $602K | Hold |
10,811
| – | – | ﹤0.01% | 1365 |
|
|
2022
Q1 | $759K | Hold |
10,811
| – | – | ﹤0.01% | 1356 |
|
|
2021
Q4 | $1.04M | Sell |
10,811
-14,250
| -57% | -$1.37M | ﹤0.01% | 1257 |
|
|
2021
Q3 | $2.18M | Hold |
25,061
| – | – | ﹤0.01% | 1073 |
|
|
2021
Q2 | $2.05M | Hold |
25,061
| – | – | ﹤0.01% | 1116 |
|
|
2021
Q1 | $2.38M | Hold |
25,061
| – | – | 0.01% | 1020 |
|
|
2020
Q4 | $1.56M | Sell |
25,061
-1,924
| -7% | -$119K | ﹤0.01% | 1201 |
|
|
2020
Q3 | $1.61M | Sell |
26,985
-30,269
| -53% | -$1.8M | ﹤0.01% | 1093 |
|
|
2020
Q2 | $4M | Buy |
57,254
+30,269
| +112% | +$2.11M | 0.01% | 677 |
|
|
2020
Q1 | $1.22M | Hold |
26,985
| – | – | ﹤0.01% | 1080 |
|
|
2019
Q4 | $1.76M | Buy |
+26,985
| New | +$1.76M | ﹤0.01% | 1112 |
|